Abstract:BACKGROUND: The broad applicability of RNA aptamers as cell-specific delivery tools for therapeutic reagents depends on the ability to identify aptamer sequences that selectively access the cytoplasm of distinct cell types. Towards this end, we have developed a novel approach that combines a cell-based selection method (cell-internalization SELEX) with high-throughput sequencing (HTS) and bioinformatics analyses to rapidly identify cell-specific, internalization-competent RNA aptamers.METHODOLOGY/PRINCIPAL FINDINGS: We demonstrate the utility of this approach by enriching for RNA aptamers capable of selective internalization into vascular smooth muscle cells (VSMCs). Several rounds of positive (VSMCs) and negative (endothelial cells; ECs) selection were performed to enrich for aptamer sequences that preferentially internalize into VSMCs. To identify candidate RNA aptamer sequences, HTS data from each round of selection were analyzed using bioinformatics methods: (1) metrics of selection enrichment; and (2) pairwise comparisons of sequence and structural similarity, termed edit and tree distance, respectively. Correlation analyses of experimentally validated aptamers or rounds revealed that the best cell-specific, internalizing aptamers are enriched as a result of the negative selection step performed against ECs.CONCLUSIONS AND SIGNIFICANCE: We describe a novel approach that combines cell-internalization SELEX with HTS and bioinformatics analysis to identify cell-specific, cell-internalizing RNA aptamers. Our data highlight the importance of performing a pre-clear step against a non-target cell in order to select for cell-specific aptamers. We expect the extended use of this approach to enable the identification of aptamers to a multitude of different cell types, thereby facilitating the broad development of targeted cell therapies.

Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents.

An exploration of aptamer internalization mechanisms and their applications in drug delivery

Aptamers: an Emerging Navigation Tool of Therapeutic Agents for Targeted Cancer Therapy

Hybrid-Type SELEX for the Selection of Artificial Nucleic Acid Aptamers Exhibiting Cell Internalization Activity

Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery

Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

Aptamers: Promising Reagents in Biomedicine Application

Aptamer-Based Targeted Delivery of Functional Nucleic Acids.

Aptamers Against Cell Surface Receptors: Selection, Modification and Application

Aptamer and Aptamer Pharmaceuticals

Clinical applications of nucleic acid aptamers in cancer.

Nucleic acid aptamers as high affinity ligands in biotechnology and biosensorics

Recent Progress and Opportunities for Nucleic Acid Aptamers

Improving synthesis and binding affinities of nucleic acid aptamers and their therapeutics and diagnostic applications

Rationally Designed Multivalent Aptamers Targeting Cell Surface for Biomedical Applications

Nucleic acid aptamers for biosensors and bio-analytical applications.

Molecular Imaging with Nucleic Acid Aptamers

Advances In The Development Of Aptamer Drug Conjugates For Targeted Drug Delivery

Advances in the Development of Aptamer Drug Conjugates for Targeted Drug Delivery.

Cell-Penetrating Peptides as Vehicles for Delivery of Therapeutic Nucleic Acids. Mechanisms and Application in Medicine